Cellular Metabolism Contributes To Therapeutic Responses in BRAF-Mutated Melanomas
Melanoma is the deadliest form of skin cancer, and virtually all patients progress on targeted therapies. Dysregulated metabolism has been shown to affect therapy response, so BRAF-mutated melanoma cell line models were used to connect cellular metabolism to therapeutic proliferative response. The d...
Main Author: | Hardeman, Keisha Nicole |
---|---|
Other Authors: | Joshua Fessel |
Format: | Others |
Language: | en |
Published: |
VANDERBILT
2017
|
Subjects: | |
Online Access: | http://etd.library.vanderbilt.edu/available/etd-04112017-094307/ |
Similar Items
-
Understanding Drug Response Dynamics in BRAF-mutated Melanoma Cells
by: Paudel, Buddhi Bishal
Published: (2018) -
Metastatic Pancreatic Cancer with BRAF and P53 Mutations: Case Report of Therapeutic Response to Doublet Targeted Therapy
by: Shenthol Sasankan, et al.
Published: (2020-10-01) -
Utilizing Systems Level Approaches to Identify Key Mechanisms of Drug Resistance in BRAF Mutated Melanoma
by: Paraiso, Kim H.T.
Published: (2015) -
Insights into the Role of Oncogenic BRAF in Tetraploidy and Melanoma Initiation
by: Darp, Revati A.
Published: (2021) -
Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032
by: Bacchiocchi Antonella, et al.
Published: (2010-07-01)